tiprankstipranks
Advertisement
Advertisement

JP:4886 Stock Latest News

ASKA Pharma revamps restricted share pay as it shifts to new governance structure
Company AnnouncementsASKA Pharma revamps restricted share pay as it shifts to new governance structure
3d ago
4886
ASKA Pharmaceutical switches auditors to EY ShinNihon to support global expansion
PremiumCompany Announcements
ASKA Pharmaceutical switches auditors to EY ShinNihon to support global expansion
3d ago
4886
ASKA Seeks Shareholder Mandate for Defense Against Potential Dalton-Led Takeover Move
PremiumCompany Announcements
ASKA Seeks Shareholder Mandate for Defense Against Potential Dalton-Led Takeover Move
3d ago
4886
ASKA Pharma to Embed Corporate Philosophy and Shift to Audit Committee Governance
PremiumCompany Announcements
ASKA Pharma to Embed Corporate Philosophy and Shift to Audit Committee Governance
3d ago
4886
ASKA Pharma Corrects Pension Accounting Data Without Affecting FY2026 Earnings
PremiumCompany Announcements
ASKA Pharma Corrects Pension Accounting Data Without Affecting FY2026 Earnings
9d ago
4886
ASKA Pharmaceutical Overhauls Board, Taps Industry Veteran for Governance Role
PremiumCompany AnnouncementsASKA Pharmaceutical Overhauls Board, Taps Industry Veteran for Governance Role
17d ago
4886
ASKA Pharmaceutical Delivers Record FY2025 Results on Overseas Expansion and Margin Gains
Premium
Company Announcements
ASKA Pharmaceutical Delivers Record FY2025 Results on Overseas Expansion and Margin Gains
17d ago
4886
ASKA Pharmaceutical Boosts Dividend as Profits Rise but Signals Margin Pressure Ahead
Premium
Company Announcements
ASKA Pharmaceutical Boosts Dividend as Profits Rise but Signals Margin Pressure Ahead
17d ago
4886
ASKA Pharmaceutical Lifts Dividend and Adopts Progressive Payout Policy
PremiumCompany Announcements
ASKA Pharmaceutical Lifts Dividend and Adopts Progressive Payout Policy
17d ago
4886
ASKA Pharmaceutical Board Rejects Activist Shareholder’s Director Proposal
PremiumCompany Announcements
ASKA Pharmaceutical Board Rejects Activist Shareholder’s Director Proposal
17d ago
4886
ASKA sets 2035 long-term vision and unveils 2028 medium-term growth plan
PremiumCompany Announcements
ASKA sets 2035 long-term vision and unveils 2028 medium-term growth plan
2M ago
4886
ASKA Pharma Launches Restricted Stock Plan for Employee Shareholders
PremiumCompany Announcements
ASKA Pharma Launches Restricted Stock Plan for Employee Shareholders
3M ago
4886
ASKA Pharmaceutical to Adopt Audit Committee Structure and Streamline Governance
PremiumCompany AnnouncementsASKA Pharmaceutical to Adopt Audit Committee Structure and Streamline Governance
3M ago
4886
ASKA Pharma Hits Record Sales but Profit Slips on Higher R&D and Overseas Costs
Premium
Company Announcements
ASKA Pharma Hits Record Sales but Profit Slips on Higher R&D and Overseas Costs
4M ago
4886
ASKA Pharmaceutical Boosts Sales but Sees Profit Decline, Keeps FY2025 Outlook Intact
Premium
Company Announcements
ASKA Pharmaceutical Boosts Sales but Sees Profit Decline, Keeps FY2025 Outlook Intact
4M ago
4886
ASKA Pharmaceutical Revises FY2025 Financial Forecasts Amid Strategic Adjustments
PremiumCompany Announcements
ASKA Pharmaceutical Revises FY2025 Financial Forecasts Amid Strategic Adjustments
7M ago
4886
ASKA Pharmaceutical Reports Q2 FY2025 Financial Results with Revised Full-Year Forecast
PremiumCompany Announcements
ASKA Pharmaceutical Reports Q2 FY2025 Financial Results with Revised Full-Year Forecast
7M ago
4886
ASKA Pharmaceutical Reports Record Sales and Raises FY2025 Forecast
PremiumCompany Announcements
ASKA Pharmaceutical Reports Record Sales and Raises FY2025 Forecast
7M ago
4886
ASKA Pharmaceutical Revises Financial Results for FY2025 Q1
PremiumCompany Announcements
ASKA Pharmaceutical Revises Financial Results for FY2025 Q1
7M ago
4886
ASKA Pharmaceutical Revises Q1 FY2025 Financial Results
PremiumCompany AnnouncementsASKA Pharmaceutical Revises Q1 FY2025 Financial Results
7M ago
4886
ASKA Secures OTC Approval for NORLEVO® Emergency Contraceptive Pill
Premium
Company Announcements
ASKA Secures OTC Approval for NORLEVO® Emergency Contraceptive Pill
7M ago
4886
ASKA Pharmaceutical Maintains Defense Against Potential Share Acquisition
Premium
Company Announcements
ASKA Pharmaceutical Maintains Defense Against Potential Share Acquisition
8M ago
4886

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >